Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2014

Aug 15, 2014

32414_dirs_2014-08-15_e9735e2d-c910-4956-bc3d-4d015d6da8ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-08-12

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-12 Common Stock P 5000 $2.285 Acquired 287971 Direct
2014-08-12 Common Stock P 10000 $2.29 Acquired 297971 Direct
2014-08-12 Common Stock P 5000 $2.295 Acquired 302971 Direct

Footnotes

F1: Acquired in open market transaction.

F2: These shares include 159,471 shares held jointly by Dr. Gold and his wife and 127,013 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.

F3: These shares include 169,471 shares held jointly by Dr. Gold and his wife and 127,013 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.

F4: These shares include 174,471 shares held jointly by Dr. Gold and his wife and 127,013 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.